The scientists supporting your research: From left to right: Dr Kiran Shabir; Dr Becky Brindley; Dr Sarah Routledge; Dr Andrew Gifford; Dr Clare Box; Dr Kevin Thompson; Ms Christine Yu; Mr Macer Gifford; Dr Maria Azam. Missing from photo: Dr Terry Tilotta. Apr...

We are looking for a Senior Scientist / Scientist to join our close knit, friendly team here in Birmingham, UK. If you have in-depth experience in receptor pharmacology, find out more about the position on our Careers page.facebooktwitterCopyright © 2021 Gifford...

Our laboratory facilities remain operational under the current national restrictions, with a suite of risk mitigation measures in place. Scientists may be working from home, however, when analyzing data or writing reports.facebooktwitterCopyright © 2008 - 2020 Gifford...

ELRIG Drug Discovery Digital 2020 is starting this week, and Dr Clare Box and Dr Kevin Thompson are going to be there, virtually, to present their research evaluating novel COVID-19 therapies through the use of SPR. ELRIG Drug Discovery DigitalfacebooktwitterCopyright...

Angiotensin II and SARS-CoV-2 ‘spike’ protein bind to independent sites on angiotensin converting enzyme 2. We used the Biacore Surface Plasmon Resonance (SPR) technique to show that the peptide angiotensin II (AT2, that is normally truncated by the ACE2 receptor) and...

Using the Biacore Surface Plasmon Resonance (SPR) technique, we have quantified the kinetic receptor binding parameters for COVID-19 / SARS-CoV-2 ‘spike’ protein to the trans-membrane receptor Angiotensin Converting Enzyme 2 (ACE2). Notably, when ACE2 is pre-mixed...